MEIP - MEI Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $9.5. This is a potential upside of $6.43 (209.45%) from yesterday's end of day stock price of $3.07.

MEI Pharma's activity chart (see below) currently has 17 price targets and 23 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.93% with an average time for these price targets to be met of 186.22 days.

Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 11-Apr-2024.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$7

$3.93 (128.01%)

$7

1 years 6 months 14 days ago
(11-Apr-2024)

0/4 (0%)

$3.73 (114.07%)

Sell

$2

$-1.07 (-34.85%)

$20

2 years 8 months 18 days ago
(07-Feb-2023)

1/3 (33.33%)

$-3.36 (-62.69%)

786

Buy

2 years 10 months 20 days ago
(05-Dec-2022)

2/2 (100%)

$-42.22 (-77.87%)

648

Buy

$6

3 years 4 months 19 days ago
(06-Jun-2022)

0/1 (0%)

$1.82 (43.54%)

Hold

$2

$-1.54 (-43.50%)

$80

3 years 7 months ago
(25-Mar-2022)

0/2 (0%)

$-7.8 (-79.59%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MEIP (MEI Pharma) average time for price targets to be met?

On average it took 186.22 days on average for the stock forecasts to be realized with a an average price target met ratio 25.93

Which analyst has the current highest performing score on MEIP (MEI Pharma) with a proven track record?

ROBYN KARNAUSKAS

Which analyst has the current lower performing score on MEIP (MEI Pharma) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on MEIP (MEI Pharma)?

Robyn Karnauskas has 3 price targets and 2 ratings on MEIP

Which analyst is the currently most bullish on MEIP (MEI Pharma)?

Stephen Willey with highest potential upside - $3.93

Which analyst is the currently most reserved on MEIP (MEI Pharma)?

Jim Birchenough with lowest potential downside - -$1.54

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?